Company Comparison
Unity Biotechnology vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Unity Biotechnology | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | South San Francisco, California | San Diego |
| Founded | 2011 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | $305M | $48M |
| Valuation | — | — |
What They Build
Unity Biotechnology
Biotechnology company developing therapeutics to halt, slow, or reverse diseases of aging by targeting senescent cells.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Unity Biotechnology
AI Therapeutics
No investors listed.
Sector Overlap
Both Unity Biotechnology and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.